Remed Co.Ltd (302550) — Capital Reinvestment Ratio
Remed Co.Ltd (302550) has a Capital Reinvestment Ratio of 0.37x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩238.69 Million) in capital expenditures (₩88.33 Million). Check 302550 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Remed Co.Ltd Capital Reinvestment Ratio (2017–2025)
This chart tracks Remed Co.Ltd's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see Remed Co.Ltd (302550) cash flow conversion.
Annual Capital Reinvestment Ratio for Remed Co.Ltd (2017–2025)
Year-by-year Capital Reinvestment Ratio for Remed Co.Ltd from 2017 to 2025. See Remed Co.Ltd (302550) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.36x | ₩2.40 Billion | ₩868.76 Million | ▼ -25.9% |
| 2024 | 0.49x | ₩1.24 Billion | ₩608.80 Million | ▲ +91.5% |
| 2023 | 0.26x | ₩3.50 Billion | ₩893.97 Million | ▼ -72.1% |
| 2022 | 0.92x | ₩5.21 Billion | ₩4.77 Billion | ▲ +248.9% |
| 2020 | 0.26x | ₩2.59 Billion | ₩679.62 Million | ▼ -57.9% |
| 2019 | 0.62x | ₩3.22 Billion | ₩2.01 Billion | ▼ -94.6% |
| 2017 | 11.52x | ₩66.75 Million | ₩768.89 Million | — |